In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 55 for your search:
Drug:  vinorelbine tartrate
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Health services research, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: IRST162.05, 2012-003544-68, NCT01848613

2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 65 and over
Sponsor: Other
Protocol IDs: INJE05-06, NCT00265694

3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 74
Sponsor: Other
Protocol IDs: HERNATA, NCT00430001

4.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2006 BAI02A02[1]-01, NCT00576914

5.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: PM 0259 CA 304 J1, NCT00683514

6.

Phase: Phase III
Type: Treatment
Status: Active
Age: Over 20
Sponsor: Other
Protocol IDs: 200803006M, NCT00776724

7.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: CDR0000633503, GOELAMS-LH2007, GOELAMS-ID-RCB#2007-A01079-44, INCA-RECF0754, AMGEN-GOELAMS-LH2007, NCT00920153

8.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: ML25241, NCT01126138

9.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: 2007048, NCT01216527

10.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 74
Sponsor: Other
Protocol IDs: C-TONG 1104, NCT01405079

11.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: DETECT III, 2010-024238-46, NCT01619111

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: McG 0713, NCT00764972

13.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: SOR507910CTIL, NCT01203735

14.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0907-002, NCT01238029

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: DO03-21-005, NCT00159094

16.

Phase: Phase II
Type: Treatment
Status: Active
Age: 1 to 25
Sponsor: Other
Protocol IDs: NAVE-CYCLO, NCT00180947

17.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: OX-03-087, ELVIS II, NCT00238849

18.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Haema CBF NSCLC UK/AS 03, NCT00168883

19.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: VinCaT, 2006-003994-28, NCT00431704

20.

Phase: Phase II
Type: Treatment
Status: Active
Age: 70 and over
Sponsor: NCI, Other
Protocol IDs: 339-07, NCI-2009-01584, P30CA036727, UNMC-33907, NCT00602797

21.

Phase: Phase II
Type: Treatment
Status: Active
Age: Over 70
Sponsor: Other
Protocol IDs: EudraCT 2005-005827-32, ML19747, NCT00678964

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000609880, YONSEI-4-2008-0132, SANOFI-AVENTIS-YONSEI-4-2008-0, 4-2008-0132, SANOFI-AVENTIS-YONSEI-4-2008-0132, NCT00736814

23.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CT/08.18, NCT00755170

24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2008-03, 2008-005013-21, NCT00985855

25.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 09.08, NCT01020864
1    
New Search